A 70-year-old woman presents with numbness and tingling that is worse in the soles of her feet. She says that symptoms started a few weeks ago and have progressively worsened. She also complains of mild nausea and white lines on her fingernails. Past medical history is significant for diabetes mellitus type 2, managed with metformin. Her last HbA1c was 5.8%. The patient denies any changes in her vision, chest pain, or palpitations. She says she lives near an industrial area that was in the newspaper for leaking waste into the groundwater but she can’t remember the details. She also says she spends a lot of her free time in her garden. On physical examination, there is decreased fine touch, temperature, and vibrational sensation in the extremities bilaterally Strength is reduced symmetrically 4 out of 5 in all limbs along with reduced (1+) deep tendon reflexes. Which of the following is the best treatment option for this patient?
Q62
A 22-year-old woman comes to the physician because of abdominal pain and diarrhea for 2 months. The pain is intermittent, colicky and localized to her right lower quadrant. She has anorexia and fears eating due to the pain. She has lost 4 kg (8.8 lb) during this time. She has no history of a serious illness and takes no medications. Her temperature is 37.8°C (100.0°F), blood pressure 125/65 mm Hg, pulse 75/min, and respirations 14/min. An abdominal examination shows mild tenderness of the right lower quadrant on deep palpation without guarding. Colonoscopy shows small aphthous-like ulcers in the right colon and terminal ileum. Biopsy from the terminal ileum shows noncaseating granulomas in all layers of the bowel wall. Which of the following is the most appropriate pharmacotherapy at this time?
Q63
A research group wants to assess the safety and toxicity profile of a new drug. A clinical trial is conducted with 20 volunteers to estimate the maximum tolerated dose and monitor the apparent toxicity of the drug. The study design is best described as which of the following phases of a clinical trial?
Q64
A 3-year-old boy is brought to his pediatrician by his mother when he developed redness, burning, itching, and exquisite pain all over his arms, lower legs, neck, and face. The mother states that she just recently began taking him to the local playground in the afternoons. She reports that she applied liberal amounts of sunscreen before and during the time outside. She states that they were at the playground for 30 minutes to 1 hour each day for the last 3 days. The patient has experienced prior episodes of redness and pain after being outdoors, but they were relatively minor and resolved within 12 hours. She says his current presentation is much more severe with more exquisite pain than in the past. The patient's vital signs are as follows: T 37.2 C, HR 98, BP 110/62, RR 16, and SpO2 99%. Physical examination reveals edema, erythema, and petechiae over the patient's face, neck, arms, and lower legs. No blistering or scarring of the skin is noted. Which of the following is the best treatment option for this patient's condition?
Q65
A 36-year-old woman comes to the physician because of prolonged stiffness in the morning and progressive pain and swelling of her wrists and hands over the past 4 months. Examination shows bilateral swelling and mild tenderness of the wrists and the second, third, and fourth metacarpophalangeal joints. Her range of motion is limited by pain. Serum studies show elevated anti-cyclic citrullinated peptide antibodies. Treatment with methotrexate is begun. At a follow-up examination, her serum aspartate aminotransferase (AST) concentration is 75 U/L and her serum alanine aminotransferase (ALT) concentration is 81 U/L. Which of the following substances is essential for the function of these enzymes?
Q66
A 45-year-old homeless man presents to the emergency department with a 1-week history of an intensely pruritic, red rash on his hands, wrists, and finger webs. The itching is worse at night. Physical examination reveals small, erythematous papules and burrows. A topical drug with which of the following mechanisms of action is most likely to be effective in treating this condition?
Q67
A 7-year-old girl is brought to the physician by her mother because of a 4-week history of irritability, diarrhea, and a 2.2-kg (5-lb) weight loss that was preceded by a dry cough. The family returned from a vacation to Indonesia 2 months ago. Her vital signs are within normal limits. Abdominal examination shows mild tenderness with no guarding or rebound and increased bowel sounds. Her leukocyte count is 9,200/mm3 with 20% eosinophils. A photomicrograph of a wet stool mount is shown. Which of the following is the most appropriate pharmacotherapy?
Q68
An 8-year-old boy is brought to the physician because of a 1-day history of severe left hand pain. He has had similar painful episodes in the past that required hospitalization. Physical examination shows pale conjunctivae. There is tenderness on palpation of the wrist and the small joints of the left hand. Peripheral blood smear shows crescent-shaped erythrocytes. He is started on a pharmacologic agent that is known to cause macrocytosis. This drug causes an arrest in which of the following cell cycle phases?
Q69
A 33-year-old woman presents to her local clinic in rural eastern India complaining of neck pain and fever. She reports a 4 day history of severe neck pain, neck stiffness, mild diarrhea, and fever. She has not taken her temperature. She works as a laborer and frequently carries heavy weights on her back. She is prescribed a medication and told to come back if her symptoms do not improve. Her symptoms resolve after a couple days. Six months later, she gives birth to a newborn male at 34 weeks gestation. His temperature is 97.8°F (36.6°C), blood pressure is 90/55 mmHg, pulse is 110/min, and respirations are 24/min. On examination, the baby is irritable with a weak cry. Ashen gray cyanosis is noted diffusely. What is the mechanism of action of the drug responsible for this child's presentation?
Q70
A 25-year-old man presents to the physician with 2 days of profuse, watery diarrhea. He denies seeing blood or mucus in the stools. On further questioning, he reveals that he eats a well-balanced diet and generally prepares his meals at home. He remembers having some shellfish from a street vendor 3 days ago. He takes no medications. His past medical history is unremarkable. Which of the following mechanisms most likely accounts for this patient’s illness?
Antimicrobials US Medical PG Practice Questions and MCQs
Question 61: A 70-year-old woman presents with numbness and tingling that is worse in the soles of her feet. She says that symptoms started a few weeks ago and have progressively worsened. She also complains of mild nausea and white lines on her fingernails. Past medical history is significant for diabetes mellitus type 2, managed with metformin. Her last HbA1c was 5.8%. The patient denies any changes in her vision, chest pain, or palpitations. She says she lives near an industrial area that was in the newspaper for leaking waste into the groundwater but she can’t remember the details. She also says she spends a lot of her free time in her garden. On physical examination, there is decreased fine touch, temperature, and vibrational sensation in the extremities bilaterally Strength is reduced symmetrically 4 out of 5 in all limbs along with reduced (1+) deep tendon reflexes. Which of the following is the best treatment option for this patient?
A. Tight control of her diabetes mellitus by adding insulin
B. Trientine
C. Calcium disodium edetate (EDTA)
D. Penicillamine
E. Dimercaprol (Correct Answer)
Explanation: ***Dimercaprol***
- The patient's symptoms, including **peripheral neuropathy** (numbness, tingling, decreased sensation, reduced strength and reflexes), **nausea**, and **Mees\' lines** (white lines on fingernails), are highly suggestive of **arsenic poisoning**.
- **Dimercaprol** is a chelating agent effective in treating heavy metal poisoning, including **arsenic**, by forming stable complexes that are then excreted.
*Tight control of her diabetes mellitus by adding insulin*
- While the patient has diabetes, her **HbA1c of 5.8%** indicates excellent glycemic control, making diabetic neuropathy less likely to be the primary cause of her acute, worsening symptoms.
- The presence of **Mees' lines** and the environmental exposure history strongly point away from uncomplicated diabetic neuropathy.
*Trientine*
- **Trientine** is a chelating agent primarily used to treat **Wilson's disease**, which involves copper overload.
- The patient's symptoms do not align with copper toxicity, and there is no indication for trientine use.
*Calcium disodium edetate (EDTA)*
- **Calcium disodium EDTA** is primarily used to treat **lead poisoning** and certain other heavy metal toxicities.
- While a chelating agent, it is not the first-line treatment for arsenic poisoning and lacks the same efficacy as dimercaprol for this specific condition.
*Penicillamine*
- **Penicillamine** is another chelating agent used for various conditions, including **Wilson's disease**, **rheumatoid arthritis**, and sometimes **lead poisoning**.
- It is not the preferred or most effective treatment for acute arsenic poisoning.
Question 62: A 22-year-old woman comes to the physician because of abdominal pain and diarrhea for 2 months. The pain is intermittent, colicky and localized to her right lower quadrant. She has anorexia and fears eating due to the pain. She has lost 4 kg (8.8 lb) during this time. She has no history of a serious illness and takes no medications. Her temperature is 37.8°C (100.0°F), blood pressure 125/65 mm Hg, pulse 75/min, and respirations 14/min. An abdominal examination shows mild tenderness of the right lower quadrant on deep palpation without guarding. Colonoscopy shows small aphthous-like ulcers in the right colon and terminal ileum. Biopsy from the terminal ileum shows noncaseating granulomas in all layers of the bowel wall. Which of the following is the most appropriate pharmacotherapy at this time?
A. Budesonide (Correct Answer)
B. Azathioprine
C. Ciprofloxacin
D. Metronidazole
E. Rectal mesalamine
Explanation: ***Budesonide***
- This patient presents with symptoms and findings (RLQ pain, aphthous ulcers, noncaseating granulomas in the terminal ileum) consistent with **Crohn's disease** isolated to the **ileum and right colon**.
- **Budesonide** is a glucocorticoid with high first-pass metabolism, making it effective for localized ileal and right colonic Crohn's disease with fewer systemic side effects than prednisone.
*Azathioprine*
- **Azathioprine** is an immunomodulator used for maintaining remission in moderate to severe Crohn's disease, not typically for acute exacerbations as first-line monotherapy.
- Its onset of action is slow (several weeks to months), making it unsuitable for immediate symptom control.
*Ciprofloxacin*
- **Ciprofloxacin** is an antibiotic mainly used when there is concern for bacterial overgrowth, abscess, or perianal disease in Crohn's, none of which are explicitly indicated here.
- There is no evidence suggesting a primary bacterial infection as the cause of her current symptoms.
*Metronidazole*
- **Metronidazole** is an antibiotic often used for Crohn's disease with perianal involvement or fistulas, and sometimes for active colonic disease, but less effective for ileal involvement.
- Like ciprofloxacin, it's not the primary treatment for uncomplicated flare of ileocolonic Crohn's.
*Rectal mesalamine*
- **Rectal mesalamine** is an aminosalicylate primarily used for mild to moderate **ulcerative colitis**, particularly proctitis or left-sided colitis due to its topical action.
- It is ineffective for Crohn's disease involving the terminal ileum and right colon, as it would not reach this location in sufficient concentration.
Question 63: A research group wants to assess the safety and toxicity profile of a new drug. A clinical trial is conducted with 20 volunteers to estimate the maximum tolerated dose and monitor the apparent toxicity of the drug. The study design is best described as which of the following phases of a clinical trial?
A. Phase 0
B. Phase III
C. Phase V
D. Phase II
E. Phase I (Correct Answer)
Explanation: ***Phase I***
- **Phase I clinical trials** involve a small group of healthy volunteers (typically 20-100) to primarily assess **drug safety**, determine a safe dosage range, and identify side effects.
- The main goal is to establish the **maximum tolerated dose (MTD)** and evaluate the drug's pharmacokinetic and pharmacodynamic profiles.
*Phase 0*
- **Phase 0 trials** are exploratory studies conducted in a very small number of subjects (10-15) to gather preliminary data on a drug's **pharmacodynamics and pharmacokinetics** in humans.
- They involve microdoses, not intended to have therapeutic effects, and thus cannot determine toxicity or MTD.
*Phase III*
- **Phase III trials** are large-scale studies involving hundreds to thousands of patients to confirm the drug's **efficacy**, monitor side effects, compare it to standard treatments, and collect information that will allow the drug to be used safely.
- These trials are conducted after safety and initial efficacy have been established in earlier phases.
*Phase V*
- "Phase V" is not a standard, recognized phase in the traditional clinical trial classification (Phase 0, I, II, III, IV).
- This term might be used in some non-standard research contexts or for post-marketing studies that go beyond Phase IV surveillance, but it is not a formal phase for initial drug development.
*Phase II*
- **Phase II trials** involve several hundred patients with the condition the drug is intended to treat, focusing on **drug efficacy** and further evaluating safety.
- While safety is still monitored, the primary objective shifts to determining if the drug works for its intended purpose and at what dose.
Question 64: A 3-year-old boy is brought to his pediatrician by his mother when he developed redness, burning, itching, and exquisite pain all over his arms, lower legs, neck, and face. The mother states that she just recently began taking him to the local playground in the afternoons. She reports that she applied liberal amounts of sunscreen before and during the time outside. She states that they were at the playground for 30 minutes to 1 hour each day for the last 3 days. The patient has experienced prior episodes of redness and pain after being outdoors, but they were relatively minor and resolved within 12 hours. She says his current presentation is much more severe with more exquisite pain than in the past. The patient's vital signs are as follows: T 37.2 C, HR 98, BP 110/62, RR 16, and SpO2 99%. Physical examination reveals edema, erythema, and petechiae over the patient's face, neck, arms, and lower legs. No blistering or scarring of the skin is noted. Which of the following is the best treatment option for this patient's condition?
A. Start therapeutic phlebotomy
B. Recommend use of a high SPF topical sunscreen
C. Prescribe chloroquine
D. Initiate oral beta carotene
E. Begin dexamethasone taper (Correct Answer)
Explanation: ***Begin dexamethasone taper***
- The patient's symptoms (redness, burning, itching, exquisite pain, edema, erythema, petechiae in sun-exposed areas) following sun exposure are highly suggestive of **erythropoietic protoporphyria (EPP)**, which is characterized by painful photosensitivity.
- While supportive care and sun protection are crucial, **oral corticosteroids** like dexamethasone can provide significant relief during acute, severe phototoxic reactions by reducing inflammation. A taper is appropriate to manage the acute exacerbation.
*Start therapeutic phlebotomy*
- **Therapeutic phlebotomy** is indicated in conditions like **hemochromatosis** to reduce iron overload.
- It is not a treatment for porphyrias, and specifically not for erythropoietic protoporphyria.
*Recommend use of a high SPF topical sunscreen*
- While **sunscreen** is generally recommended for sun protection, it is typically **ineffective** in preventing the reactions seen in photosensitivity disorders like EPP because the relevant light wavelengths (visible light) often penetrate, and the underlying mechanism is not superficial UV damage.
- The patient's mother already applied liberal amounts of sunscreen, yet the symptoms occurred, further suggesting it's not adequate for this condition.
*Prescribe chloroquine*
- **Chloroquine** (and hydroxychloroquine) is used in some porphyrias, specifically **porphyria cutanea tarda (PCT)**, to chelate and remove porphyrins.
- However, it can **exacerbate** EPP due to its effects on porphyrin metabolism and liver function, making it contraindicated in this condition.
*Initiate oral beta carotene*
- **Oral beta-carotene** is sometimes used as a photoprotective agent in certain photosensitivity disorders, including EPP, to increase the threshold for light exposure.
- While it can be a part of long-term management, it is primarily a **prophylactic** measure and is generally **not effective for treating acute, severe exacerbations** or providing rapid relief from acute pain and inflammation.
Question 65: A 36-year-old woman comes to the physician because of prolonged stiffness in the morning and progressive pain and swelling of her wrists and hands over the past 4 months. Examination shows bilateral swelling and mild tenderness of the wrists and the second, third, and fourth metacarpophalangeal joints. Her range of motion is limited by pain. Serum studies show elevated anti-cyclic citrullinated peptide antibodies. Treatment with methotrexate is begun. At a follow-up examination, her serum aspartate aminotransferase (AST) concentration is 75 U/L and her serum alanine aminotransferase (ALT) concentration is 81 U/L. Which of the following substances is essential for the function of these enzymes?
A. Thiamine
B. Pyridoxine (Correct Answer)
C. Folic acid
D. Riboflavin
E. Niacin
Explanation: ***Pyridoxine***
- **Pyridoxine (Vitamin B6)** is a crucial **cofactor** for **aminotransferase enzymes** like AST and ALT, functioning as **pyridoxal phosphate (PLP)**.
- In the context of **methotrexate treatment**, monitoring liver enzymes is essential due to potential **hepatotoxicity**, and disturbances in pyridoxine metabolism can impact enzyme activity.
*Thiamine*
- **Thiamine (Vitamin B1)** is essential for enzymes involved in **carbohydrate metabolism**, particularly in the form of **thiamine pyrophosphate (TPP)**.
- It plays a primary role in reactions such as those catalyzed by **pyruvate dehydrogenase** and **alpha-ketoglutarate dehydrogenase**, not aminotransferases.
*Folic acid*
- **Folic acid (Vitamin B9)** is primarily involved in **one-carbon metabolism**, including **DNA synthesis** and repair.
- It is not a cofactor for AST or ALT; however, **leucovorin (folinic acid)** is often co-administered with methotrexate to mitigate its side effects.
*Riboflavin*
- **Riboflavin (Vitamin B2)** is a precursor for **flavin adenine dinucleotide (FAD)** and **flavin mononucleotide (FMN)**, which are cofactors for **redox reactions**.
- Enzymes like **succinate dehydrogenase** and **acyl-CoA dehydrogenase** require riboflavin, but not AST or ALT.
*Niacin*
- **Niacin (Vitamin B3)** is a precursor for **nicotinamide adenine dinucleotide (NAD+)** and **nicotinamide adenine dinucleotide phosphate (NADP+)**, which are vital for many **dehydrogenase reactions**.
- These coenzymes are crucial for **energy metabolism**, but not directly for the catalytic activity of aminotransferases.
Question 66: A 45-year-old homeless man presents to the emergency department with a 1-week history of an intensely pruritic, red rash on his hands, wrists, and finger webs. The itching is worse at night. Physical examination reveals small, erythematous papules and burrows. A topical drug with which of the following mechanisms of action is most likely to be effective in treating this condition?
A. Increase in keratinocyte turnover
B. Inhibition of histamine-1 receptors
C. Decrease in peptidoglycan synthesis
D. Inhibition of nuclear factor-κB
E. Binding to sodium channels (Correct Answer)
Explanation: ***Binding to sodium channels***
- The clinical presentation of **intensely pruritic rash**, especially worse at night, with **burrows** on hands, wrists, and finger webs, is highly suggestive of **scabies**.
- Scabies is caused by the mite *Sarcoptes scabiei*, and treatment often involves **permethrin**, which acts by **binding to sodium channels** in the mite's nervous system, leading to paralysis and death.
*Increase in keratinocyte turnover*
- This mechanism of action is characteristic of drugs used to treat conditions like **psoriasis**, where the goal is to reduce rapid skin cell proliferation.
- It is not relevant for parasitic infestations like scabies, which require an agent to directly kill the mites.
*Inhibition of histamine-1 receptors*
- Antihistamines, which block H1 receptors, are used to alleviate **pruritus** associated with allergic reactions or other inflammatory skin conditions.
- While they can help with the *symptom* of itching, they do not address the underlying *cause* of scabies (the mite infestation itself).
*Decrease in peptidoglycan synthesis*
- This mechanism is characteristic of **antibiotics** like **penicillins** and **cephalosporins**, which target the bacterial cell wall.
- It is effective against bacterial infections but has no utility in treating parasitic infestations like scabies, which are caused by arthropods, not bacteria.
*Inhibition of nuclear factor-κB*
- **NF-κB** is a protein complex that controls **transcription of DNA**, cytokine production, and cell survival, and its inhibition is often targeted in **inflammatory diseases** or cancers.
- This mechanism is not directly involved in the eradication of scabies mites.
Question 67: A 7-year-old girl is brought to the physician by her mother because of a 4-week history of irritability, diarrhea, and a 2.2-kg (5-lb) weight loss that was preceded by a dry cough. The family returned from a vacation to Indonesia 2 months ago. Her vital signs are within normal limits. Abdominal examination shows mild tenderness with no guarding or rebound and increased bowel sounds. Her leukocyte count is 9,200/mm3 with 20% eosinophils. A photomicrograph of a wet stool mount is shown. Which of the following is the most appropriate pharmacotherapy?
A. Diethylcarbamazine
B. Metronidazole
C. Albendazole (Correct Answer)
D. Praziquantel
E. Doxycycline
Explanation: ***Albendazole***
- The image shows a **hookworm egg**, characterized by its thin shell and developing larva inside; clinical features like **eosinophilia**, diarrhea, weight loss, and travel to an endemic area (Indonesia) are consistent with hookworm infection.
- **Albendazole** is the drug of choice for treating hookworm infections and other intestinal nematode infections.
*Diethylcarbamazine*
- This drug is primarily used for treating **lymphatic filariasis** (e.g., Wuchereria bancrofti, Brugia malayi) and **Loiasis** (African eye worm).
- It is not effective against hookworm infections.
*Metronidazole*
- **Metronidazole** is an antimicrobial agent effective against certain parasitic infections like **Giardia**, **Entamoeba histolytica**, and bacterial vaginosis.
- It is not indicated for the treatment of hookworm infections.
*Praziquantel*
- **Praziquantel** is an anthelminthic drug primarily used to treat infections caused by **flukes** (e.g., Schistosoma species) and **tapeworms** (e.g., Taenia species).
- It is not effective against hookworm infections.
*Doxycycline*
- **Doxycycline** is a tetracycline antibiotic with broad-spectrum activity against various bacterial infections and is also used in the treatment of some parasitic infections like **malaria prophylaxis** and **filariasis** (due to activity against Wolbachia endosymbionts).
- It is not a primary treatment for hookworm infections.
Question 68: An 8-year-old boy is brought to the physician because of a 1-day history of severe left hand pain. He has had similar painful episodes in the past that required hospitalization. Physical examination shows pale conjunctivae. There is tenderness on palpation of the wrist and the small joints of the left hand. Peripheral blood smear shows crescent-shaped erythrocytes. He is started on a pharmacologic agent that is known to cause macrocytosis. This drug causes an arrest in which of the following cell cycle phases?
A. S phase (Correct Answer)
B. G0 phase
C. G2 phase
D. M phase
E. G1 phase
Explanation: ***S phase***
- This patient presents with **sickle cell disease** given the history of recurrent severe pain episodes, pale conjunctivae (suggesting anemia), and **crescent-shaped erythrocytes** on peripheral blood smear.
- The pharmacologic agent that causes **macrocytosis** and is used in sickle cell disease is **hydroxyurea** through increasing **fetal hemoglobin**; it primarily works by inhibiting **ribonucleotide reductase**, an enzyme essential for **DNA synthesis**, thereby arresting cells in the **S phase**.
*G0 phase*
- The **G0 phase** is a resting phase where cells are not actively dividing or preparing to divide.
- Hydroxyurea targets rapidly dividing cells by interfering with DNA replication, so it does not primarily arrest cells in the inactive G0 phase.
*G2 phase*
- The **G2 phase** is the growth phase where the cell checks its DNA and prepares for mitosis.
- While hydroxyurea can indirectly affect the G2/M checkpoint, its direct mechanism of action is primarily in the S phase by preventing proper DNA synthesis.
*M phase*
- The **M phase** is the stage of cell division, including mitosis and cytokinesis.
- Drugs that block the M phase typically interfere with **microtubule formation** (e.g., vinca alkaloids, taxanes), which is not the primary mechanism of hydroxyurea.
*G1 phase*
- The **G1 phase** is the initial growth phase where the cell grows and synthesizes proteins.
- While cells must pass through G1 before entering S phase, hydroxyurea's direct DNA synthesis inhibition occurs during the S phase rather than preventing entry into S from G1.
Question 69: A 33-year-old woman presents to her local clinic in rural eastern India complaining of neck pain and fever. She reports a 4 day history of severe neck pain, neck stiffness, mild diarrhea, and fever. She has not taken her temperature. She works as a laborer and frequently carries heavy weights on her back. She is prescribed a medication and told to come back if her symptoms do not improve. Her symptoms resolve after a couple days. Six months later, she gives birth to a newborn male at 34 weeks gestation. His temperature is 97.8°F (36.6°C), blood pressure is 90/55 mmHg, pulse is 110/min, and respirations are 24/min. On examination, the baby is irritable with a weak cry. Ashen gray cyanosis is noted diffusely. What is the mechanism of action of the drug responsible for this child's presentation?
A. DNA-dependent RNA polymerase inhibitor
B. Dihydropteroate synthase inhibitor
C. DNA gyrase inhibitor
D. 30S ribosomal subunit inhibitor
E. 50S ribosomal subunit inhibitor (Correct Answer)
Explanation: ***50S ribosomal subunit inhibitor***
- The mother's symptoms (neck pain, stiffness, fever, mild diarrhea) and rapid improvement suggest a bacterial infection treated with an antibiotic. Given the newborn's presentation of **gray baby syndrome** (ashen gray cyanosis, irritability, weak cry, hypothermia, hypotension), the likely causative drug is **chloramphenicol**.
- **Chloramphenicol** inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit**, which can cause idiosyncratic toxicity in neonates due to underdeveloped glucuronidation enzymes needed for its metabolism.
*DNA-dependent RNA polymerase inhibitor*
- This mechanism describes drugs like **rifampin**, which is primarily used for **tuberculosis** and does not cause gray baby syndrome.
- Rifampin's side effects include **red-orange discoloration** of bodily fluids and **hepatotoxicity**, which are distinct from the described neonatal symptoms.
*Dihydropteroate synthase inhibitor*
- This mechanism is characteristic of **sulfonamides** (e.g., sulfamethoxazole), which inhibit folic acid synthesis in bacteria.
- Sulfonamides are associated with **kernicterus** in neonates (due to displacement of bilirubin from albumin), not gray baby syndrome.
*DNA gyrase inhibitor*
- This describes **fluoroquinolones** (e.g., ciprofloxacin), which block bacterial DNA replication and transcription.
- Fluoroquinolones are generally **contraindicated in pregnancy and children** due to concerns about cartilage damage, but they do not cause gray baby syndrome.
*30S ribosomal subunit inhibitor*
- This mechanism is used by **tetracyclines** and **aminoglycosides**.
- **Tetracyclines** can cause **tooth discoloration** and **bone growth inhibition** in children, while **aminoglycosides** are associated with **ototoxicity** and **nephrotoxicity**; neither causes gray baby syndrome.
Question 70: A 25-year-old man presents to the physician with 2 days of profuse, watery diarrhea. He denies seeing blood or mucus in the stools. On further questioning, he reveals that he eats a well-balanced diet and generally prepares his meals at home. He remembers having some shellfish from a street vendor 3 days ago. He takes no medications. His past medical history is unremarkable. Which of the following mechanisms most likely accounts for this patient’s illness?
A. Tyrosine kinase phosphorylation
B. ADP-ribosylation of Gs protein (Correct Answer)
C. Tyrosine kinase dephosphorylation
D. Osmotic effect of intestinal contents
E. Inflammation of the gastrointestinal wall
Explanation: ***ADP-ribosylation of Gs protein***
- The patient's history of consuming **shellfish from a street vendor** and presenting with **profuse, watery diarrhea** strongly suggests **cholera**.
- **Cholera toxin** works by irreversibly ADP-ribosylating the **Gs alpha subunit**, leading to constitutive activation of **adenylate cyclase** and increased intracellular **cAMP**, which causes excessive fluid and electrolyte secretion into the intestinal lumen.
*Tyrosine kinase phosphorylation*
- This mechanism is characteristic of signaling pathways involved in growth and differentiation, often seen with **growth factor receptors**, and is not the primary cause of acute, watery diarrhea from food poisoning.
- While some bacterial toxins can affect intracellular signaling, **tyrosine kinase phosphorylation** is not the direct mechanism for the massive fluid loss seen in cholera.
*Tyrosine kinase dephosphorylation*
- This process typically downregulates cell signaling pathways, which would likely **decrease** cellular activity, rather than trigger the profuse secretion seen in this patient's presentation.
- It is not a known mechanism for the pathogenesis of infectious diarrheal diseases such as cholera.
*Osmotic effect of intestinal contents*
- While **osmotic diarrhea** is characterized by the presence of non-absorbable solutes in the gut lumen, drawing water in, the history here points more to an actively secreted fluid loss.
- The sheer volume and rapid onset of the diarrhea suggest an active secretory mechanism rather than simply an osmotic effect from malabsorption.
*Inflammation of the gastrointestinal wall*
- **Inflammatory diarrhea** typically involves blood or mucus in the stool, fever, and abdominal pain, none of which are reported by the patient.
- The patient's "profuse, watery" diarrhea without blood or mucus signifies a non-inflammatory, secretory etiology often caused by toxins.